Your browser doesn't support javascript.
loading
Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain.
Garrick, Jacqueline M; Dao, Khoi; Costa, Lucio G; Marsillach, Judit; Furlong, Clement E.
Afiliación
  • Garrick JM; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA. jacqueg@uw.edu.
  • Dao K; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
  • Costa LG; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
  • Marsillach J; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Furlong CE; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
BMC Neurosci ; 23(1): 52, 2022 09 02.
Article en En | MEDLINE | ID: mdl-36056313
ABSTRACT

BACKGROUND:

Paraoxonase 2 (PON2) is an intracellular antioxidant enzyme located at the inner mitochondrial membrane. Previous studies have found PON2 to be an important antioxidant in a variety of cellular systems, such as the cardiovascular and renal system. Recent work has also suggested that PON2 plays an important role in the central nervous system (CNS), as decreased PON2 expression in the CNS leads to higher oxidative stress and subsequent cell toxicity. However, the precise role of PON2 in the CNS is still largely unknown, and what role it may play in specific regions of the brain remains unexamined. Dopamine metabolism generates considerable oxidative stress and antioxidant function is critical to the survival of dopaminergic neurons, providing a potential mechanism for PON2 in the dopaminergic system.

METHODS:

In this study, we investigated the role of PON2 in the dopaminergic system of the mouse brain by comparing transcript and protein expression of dopaminergic-related genes in wildtype (WT) and PON2 deficient (PON2-def) mouse striatum, and exposing WT cultured primary neurons to dopamine receptor agonists.

RESULTS:

We found alterations in multiple key dopaminergic genes at the transcript level, however many of these changes were not observed at the protein level. In cultured neurons, PON2 mRNA and protein were increased upon exposure to quinpirole, a dopamine receptor 2/3 (DRD2/3) agonist, but not fenoldopam, a dopamine receptor 1/5 (DRD1/5) agonist, suggesting a receptor-specific role in dopamine signaling.

CONCLUSIONS:

Our findings suggest PON2 deficiency significantly impacts the dopaminergic system at the transcript level and may play a role in mitigating oxidative stress in this system further downstream through dopamine receptor signaling.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Arildialquilfosfatasa Límite: Animals Idioma: En Revista: BMC Neurosci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Encéfalo / Arildialquilfosfatasa Límite: Animals Idioma: En Revista: BMC Neurosci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos